Levamlodipine Maleate is the pharmacologically active S-enantiomer of the dihydropyridine calcium channel blocker amlodipine, commonly prescribed for the management of hypertension and angina pectoris.… Read more
Levamlodipine Maleate is the pharmacologically active S-enantiomer of the dihydropyridine calcium channel blocker amlodipine, commonly prescribed for the management of hypertension and angina pectoris. By selectively inhibiting L-type calcium channels in vascular smooth muscle, this compound effectively regulates blood pressure. To ensure accurate regulatory compliance and quality control, analytical laboratories require high-quality reference standards for Levamlodipine Maleate, including its related impurities, degradants, and specific salt forms like levamlodipine aspartate. These reference materials are critical for impurity profiling and method validation during pharmaceutical development and manufacturing processes. Chemists often rely on stable isotope labelled compounds and authenticated reference standards to facilitate precise quantification and structural identification, ensuring that formulations meet strict pharmacopeial standards throughout the lifecycle of the drug product.